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Background
Widespread use of organophosphorous compounds
(OPs) in agriculture and as nerve agents as well as a lack
of clinically effective antidotes initiated the synthesis of
new pyridinium bis-aldoximes (K-compounds) with high
potency in reactivating acetylcholinesterase irreversibly
inhibited by OPs [1,2]. We aimed to optimize an HPLC
method sensitive enough to determine K-compounds
from different biological matrices (blood, brain and cere-
brospinal fluid) [3,4].
Methods
Samples of biological origin needed proper clean-up. An
RP-HPLC method using either UV and amperometric
detector was used following separation on a Zorbax Rx-
C18 octadecyl silica column with a mobile phase of phos-
phate buffer with 20% acetonitrile (pH 3.7). 1-Octane sul-
phonic acid sodium salt (OSA) was used as ion-pairing
agent. Calculation of theoretical plate number, asymmetry
of peaks, limit of quantitation (LOQ), lower limit of detec-
tion (LLOD) and determination of pH, temperature and
OSA concentration dependence was done.
Results
Elution characteristics of bis-pyridinium mono-aldoximes
were depending on the OSA concentration, however, to a
lesser extent than the bis-pyridinium bis-aldoximes. A
double bond in the alkyl chain decreased the dependence
from the ion-pairing agent concentration only to a minor
extent. When the samples were kept at a pH under 1.5 a
peak of degradation product was generated. The time
course of degradation in an acidic milieu was calculated.
Conclusions
Appropriate clean-up, optimal concentration of the ion-
pairing agent and a well-selected mode of detection are
the key factors for optimal determinations. We point out
decomposition of pyridinium aldoximes at acidic pH.
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